Celltrion’s Remsima SC Ready For Early 2020 Launch

Formal EU Approval Received For ‘Biobetter’ Subcutaneous Infliximab

 
• By David Wallace
  
2020_Cranes
Everything is falling into place for Celltrion’s subcutaneous infliximab launch in early 2020 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products